Pfizer Archives - The Online Citizen

India’s manufacturing woes: Production challenges faced by Pfizer and Apple

India’s manufacturing sector faces significant challenges as Pfizer and Apple encounter production issues. Pfizer suspended the sale of four antibiotics due to manufacturing deviations at a contractor plant. Apple struggles with weak infrastructure, logistics, and low yield in its manufacturing operations. India’s lack of robust infrastructure, shortage of skilled labor, complex regulations, and bureaucratic hurdles contribute to the difficulties faced by multinational companies. Despite attempts to attract foreign investment, many firms have opted to leave India.

Correspondent
13 June 2023

EU approves first vaccine against common respiratory virus

The European Commission has approved the world’s first vaccine for Respiratory Syncytial Virus (RSV) in adults aged 60 and over. GSK, the maker of the vaccine called Arexvy, stated that this authorization allows eligible adults to be vaccinated against RSV for the first time. RSV can cause severe illness in vulnerable populations and has led to approximately 20,000 in-hospital deaths each year in Europe among adults aged 60 and over. The market for RSV vaccines is projected to exceed $10 billion in the coming decade.

The Online Citizen
7 June 2023

Singapore’s Health Sciences Authority approves Pfizer’s PCV20 vaccine for adults over 18

Pfizer’s 20-valent pneumococcal conjugate vaccine, APEXXNAR, has been approved by the Singapore Health Sciences Authority for adults aged 18 and above, becoming the first 20-valent pneumococcal conjugate vaccine to be approved in Southeast Asia. The vaccine offers protection against invasive pneumococcal disease and pneumonia caused by 20 Streptococcus pneumoniae serotypes.